SUBSCRIBE
SUBSCRIBE
News   Deals

Heart-Valve Win May Prod Johnson & Johnson, Abbott Laboratories to Shop for Technology

November 10, 2010 | 
1 min read
Bloomberg -- Abbott Laboratories and Johnson & Johnson, pursuing a potential $2 billion market for heart valves that don’t require rib-cracking surgery, are shopping for companies with the new technology.
Mergers & acquisitions
Johnson & Johnson Family of Companies Abbott Laboratories
MORE ON THIS TOPIC
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
February 11, 2026
 · 
2 min read
 · 
Tristan Manalac
3d illustration of a robotic hand holding a medical capsule on blue backdrop with space for text and images. Concept of automated medical treatment.
Artificial intelligence
AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery
February 11, 2026
 · 
8 min read
 · 
Annalee Armstrong
Creativity and new ideas in business. Art collage.
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
February 9, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker